Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

51.45 +1.18 (+2.35%)
Streaming Delayed Price Updated: 3:01 PM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Roche Holding AG Basel American Depositary Shares

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
34 35 Next >
News headline image
Global Diversification: Switzerland And The Philippines ↗
One way to avoid or defend against slowing growth in the US is to own positions in other countries. There is likely a fund for almost any developed country you can think of that owns a basket of stocks... 
Via Talk Markets
News headline image
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings ↗
Big pharma reporting season was muted, with the quarterly results and guidance coming in mixed. 
Via Benzinga
News headline image
A News Blizzard ↗
Markets are still down despite very encouraging news in January when 467,00 new hires got jobs. 
Via Talk Markets
News headline image
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
News headline image
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests ↗
Roche Holdings AG's (OTC: RHHBY) FY21 sales increased 8% Y/Y (9% on a constant currency basis) to CH 
Via Benzinga
News headline image
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues ↗
Novartis AG (NYSE: NVS) reported a Q4 net income of $16.31 billion, up from $2.1 billion the previous year,  
Via Benzinga
News headline image
World Markets News for Tuesday ↗
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon. 
Via Talk Markets
News headline image
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab ↗
Biogen Inc (NASDAQ: BIIB) has  
Via Benzinga
News headline image
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
News headline image
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo ↗
The FDA has approved Genentech's, a unit of  
Via Benzinga
News headline image
FDA Approves Genentech’s Vabysmo, the First Bispecific Antibody for the Eye, to Treat Two Leading Causes of Vision Loss
From Genentech
Via Business Wire
News headline image
Drug Troubles ↗
The drug sector has both good news and bad. 
Via Talk Markets
News headline image
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months ↗
The FDA has granted priority review for Genentech's, a unit of Roche Holdings AG (OTC: RHHBY) supplemental marketing application for Evrysdi (... 
Via Benzinga
News headline image
These OTC Securities Had the Most Trading Activity in December ↗
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be i... 
Via Benzinga
News headline image
Genentech’s Evrysdi (risdiplam) Granted FDA Priority Review for Treatment of Pre-Symptomatic Babies Under 2 Months of Age With Spinal Muscular Atrophy (SMA)
From Genentech
Via Business Wire
News headline image
The Lancet Publishes Studies Showing Genentech’s Faricimab Improved and Maintained Vision in Two Leading Causes of Vision Loss, Extending Time Between Treatments up to Four Months
From Genentech
Via Business Wire
News headline image
The Week Ahead In Biotech (Jan. 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, & More ↗
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that... 
Via Talk Markets
News headline image
Chopped Stocks ↗
The day's theme is sell tech and buy banks. 
Via Talk Markets
News headline image
MLK Day Global News ↗
In Q4 China's GDP growth rate halved to 4%. 
Via Talk Markets
News headline image
More Serious Matters ↗
Wall Street fell on new worries about inflation and a drop in retail sales levels. 
Via Talk Markets
Breast Cancer Treatment Advancements Emerge After New Study Finds Global Deaths Increased in 2019
FN Media Group Presents USA News Group News Commentary Vancouver, BC – January 14, 2022 – USA News Group – Cancer cases are on the rise, according to a new study comparing the number of cancer... 
Via FinancialNewsMedia
Topics Death
News headline image
Interest Rate Hikes And Stocks ↗
Abnormal flooding in northwest Brazil has blocked iron ore mining which resulted in a jump in the price of ore. 
Via Talk Markets
News headline image
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply ↗
The Centers for Medicare & Medicaid Services (CMS) released a proposed national coverage determination for Medicare to cover drugs that target amyloid for mild... 
Via Benzinga
News headline image
Happy New Year - Sunday Edition ↗
Starting a new year - we look at tech, pharma and mining stocks and their goings-on. 
Via Talk Markets
News headline image
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates ↗
Regulatory decisions by the U.S. Food and Drug Administration in December turned out to be mostly positive. Among the treatment options that were greenlighted in the month were... 
Via Benzinga
News headline image
Healthcare Stocks Are Winners And Provide Diversification To Your Portfolio ↗
As we have written their year many times speculative small cap biotechs have not done well in 2021 since they peaked in February. 
Via Talk Markets
News headline image
Boxing Day Finance ↗
Today we saw the Dow Jones move up over 36,000. 
Via Talk Markets
News headline image
Free COVID Tests: What Stocks Will Benefit? ↗
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits. 
Via Talk Markets
News headline image
Biotech Playbook 2021 Part 2: Rotation Rally Brings Relief after FED Pivot ↗
The new aggressive Fed taper combined with a rise in interest rates for 2022 adds a new element of risk to portfolio management. Monetary policy is a headwind for 2022. 
Via Talk Markets
News headline image
Dreaming Of A Red Christmas ↗
The stock market is reacting with lots of selling to the weekend's news. 
Via Talk Markets
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
34 35 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.